Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
The Journal of Steroid Biochemistry and Molecular Biology|December 24, 2008
8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activityElisa Brunelli, Giulia Pinton, Federica Chianale, et al.Fitoterapia|April 18, 2009
Flavonoid-induced autophagy in hormone sensitive breast cancer cellsElisa Brunelli, Giulia Pinton, Paolo Bellini, et al.Bioinorganic Chemistry and Applications|January 9, 2023
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular UptakeElisabetta Gabano, Ilaria Zanellato, Giulia Pinton, et al.Plos One|October 15, 2011
Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stabilityArcangela Gabriella Manente, Giulia Pinton, Daniela Tavian, et al.Journal of Cellular and Molecular Medicine|January 11, 2013
PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1Giulia Pinton, Arcangela Gabriella Manente, Bruno Murer, et al.Molecules (Basel, Switzerland)|August 27, 2021
Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell LinesElisabetta Gabano, Giulia Pinton, Cecilia Balzano, et al.Molecular Cancer|October 4, 2014
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicityGiulia Pinton, Arcangela G Manente, Antonio Daga, et al.Cell Death & Disease|February 3, 2017
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxiaSara Zonca, Giulia Pinton, Zhuo Wang, et al.Oncotarget|July 26, 2015
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cellsArcangela G Manente, Giulia Pinton, Sara Zonca, et al.Frontiers in Oncology|December 12, 2022
Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibitionGiulia Pinton, Zhuo Wang, Cecilia Balzano, et al.Pageof 4